The potential relevance of IGFs to ovarian physiology: Recent developments

E. Y. Adashi, C. E. Resnick, A. Hurwitz, E. Ricciarelli, E. R. Hernandez, Ronald (Ron) Rosenfeld, Charles Roberts, D. LeRoith

Research output: Contribution to journalArticle

Abstract

As the significance of putative intraovarian regulators became increasingly evident, much of the attention has focused on insulin-like growth factors (IGFs). Indeed, a large body of evidence now suggests the existence of an intraovarian IGF system replete with ligands, receptors, and binding proteins. IGFs have been shown to exert a variety of significant effects at the level of somatic ovarian cells thereby raising the possibility of a meaningful role in vivo. Nonetheless, there is at this time no compelling evidence to indicate that IGFs (or, for that matter, any other putative intraovarian regulator) are indispensable to ovarian function. However, a relatively large body of indirect evidence strongly does support such a possibility. It will be the purpose of the presentation to review key developments in this area in the hope of supporting the notion that ovarian IGFs may serve as amplifiers of gonadotropin hormonal action and that some IGFBPs may possess antigonadotropic properties. Moreover, preliminary evidence will be discussed to support the notion that optimal FSH hormonal action may be contingent upon the bioavailability of endogenously-derived IGFs.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalContraception Fertilite Sexualite
Volume19
Issue number1
StatePublished - 1991
Externally publishedYes

Fingerprint

Somatomedins
Insulin-Like Growth Factor Binding Proteins
Gonadotropins
Biological Availability
Carrier Proteins
Ligands

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Adashi, E. Y., Resnick, C. E., Hurwitz, A., Ricciarelli, E., Hernandez, E. R., Rosenfeld, R. R., ... LeRoith, D. (1991). The potential relevance of IGFs to ovarian physiology: Recent developments. Contraception Fertilite Sexualite, 19(1), 29-34.

The potential relevance of IGFs to ovarian physiology : Recent developments. / Adashi, E. Y.; Resnick, C. E.; Hurwitz, A.; Ricciarelli, E.; Hernandez, E. R.; Rosenfeld, Ronald (Ron); Roberts, Charles; LeRoith, D.

In: Contraception Fertilite Sexualite, Vol. 19, No. 1, 1991, p. 29-34.

Research output: Contribution to journalArticle

Adashi, EY, Resnick, CE, Hurwitz, A, Ricciarelli, E, Hernandez, ER, Rosenfeld, RR, Roberts, C & LeRoith, D 1991, 'The potential relevance of IGFs to ovarian physiology: Recent developments', Contraception Fertilite Sexualite, vol. 19, no. 1, pp. 29-34.
Adashi EY, Resnick CE, Hurwitz A, Ricciarelli E, Hernandez ER, Rosenfeld RR et al. The potential relevance of IGFs to ovarian physiology: Recent developments. Contraception Fertilite Sexualite. 1991;19(1):29-34.
Adashi, E. Y. ; Resnick, C. E. ; Hurwitz, A. ; Ricciarelli, E. ; Hernandez, E. R. ; Rosenfeld, Ronald (Ron) ; Roberts, Charles ; LeRoith, D. / The potential relevance of IGFs to ovarian physiology : Recent developments. In: Contraception Fertilite Sexualite. 1991 ; Vol. 19, No. 1. pp. 29-34.
@article{865ae02c33c7483db21411cf5d4b9af5,
title = "The potential relevance of IGFs to ovarian physiology: Recent developments",
abstract = "As the significance of putative intraovarian regulators became increasingly evident, much of the attention has focused on insulin-like growth factors (IGFs). Indeed, a large body of evidence now suggests the existence of an intraovarian IGF system replete with ligands, receptors, and binding proteins. IGFs have been shown to exert a variety of significant effects at the level of somatic ovarian cells thereby raising the possibility of a meaningful role in vivo. Nonetheless, there is at this time no compelling evidence to indicate that IGFs (or, for that matter, any other putative intraovarian regulator) are indispensable to ovarian function. However, a relatively large body of indirect evidence strongly does support such a possibility. It will be the purpose of the presentation to review key developments in this area in the hope of supporting the notion that ovarian IGFs may serve as amplifiers of gonadotropin hormonal action and that some IGFBPs may possess antigonadotropic properties. Moreover, preliminary evidence will be discussed to support the notion that optimal FSH hormonal action may be contingent upon the bioavailability of endogenously-derived IGFs.",
author = "Adashi, {E. Y.} and Resnick, {C. E.} and A. Hurwitz and E. Ricciarelli and Hernandez, {E. R.} and Rosenfeld, {Ronald (Ron)} and Charles Roberts and D. LeRoith",
year = "1991",
language = "English (US)",
volume = "19",
pages = "29--34",
journal = "Gynecologie Obstetrique Fertilite et Senologie",
issn = "2468-7197",
publisher = "Elsevier Masson SAS",
number = "1",

}

TY - JOUR

T1 - The potential relevance of IGFs to ovarian physiology

T2 - Recent developments

AU - Adashi, E. Y.

AU - Resnick, C. E.

AU - Hurwitz, A.

AU - Ricciarelli, E.

AU - Hernandez, E. R.

AU - Rosenfeld, Ronald (Ron)

AU - Roberts, Charles

AU - LeRoith, D.

PY - 1991

Y1 - 1991

N2 - As the significance of putative intraovarian regulators became increasingly evident, much of the attention has focused on insulin-like growth factors (IGFs). Indeed, a large body of evidence now suggests the existence of an intraovarian IGF system replete with ligands, receptors, and binding proteins. IGFs have been shown to exert a variety of significant effects at the level of somatic ovarian cells thereby raising the possibility of a meaningful role in vivo. Nonetheless, there is at this time no compelling evidence to indicate that IGFs (or, for that matter, any other putative intraovarian regulator) are indispensable to ovarian function. However, a relatively large body of indirect evidence strongly does support such a possibility. It will be the purpose of the presentation to review key developments in this area in the hope of supporting the notion that ovarian IGFs may serve as amplifiers of gonadotropin hormonal action and that some IGFBPs may possess antigonadotropic properties. Moreover, preliminary evidence will be discussed to support the notion that optimal FSH hormonal action may be contingent upon the bioavailability of endogenously-derived IGFs.

AB - As the significance of putative intraovarian regulators became increasingly evident, much of the attention has focused on insulin-like growth factors (IGFs). Indeed, a large body of evidence now suggests the existence of an intraovarian IGF system replete with ligands, receptors, and binding proteins. IGFs have been shown to exert a variety of significant effects at the level of somatic ovarian cells thereby raising the possibility of a meaningful role in vivo. Nonetheless, there is at this time no compelling evidence to indicate that IGFs (or, for that matter, any other putative intraovarian regulator) are indispensable to ovarian function. However, a relatively large body of indirect evidence strongly does support such a possibility. It will be the purpose of the presentation to review key developments in this area in the hope of supporting the notion that ovarian IGFs may serve as amplifiers of gonadotropin hormonal action and that some IGFBPs may possess antigonadotropic properties. Moreover, preliminary evidence will be discussed to support the notion that optimal FSH hormonal action may be contingent upon the bioavailability of endogenously-derived IGFs.

UR - http://www.scopus.com/inward/record.url?scp=0026034956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026034956&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026034956

VL - 19

SP - 29

EP - 34

JO - Gynecologie Obstetrique Fertilite et Senologie

JF - Gynecologie Obstetrique Fertilite et Senologie

SN - 2468-7197

IS - 1

ER -